[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES533995A0 - Procedimiento para preparar imidasoles - Google Patents

Procedimiento para preparar imidasoles

Info

Publication number
ES533995A0
ES533995A0 ES533995A ES533995A ES533995A0 ES 533995 A0 ES533995 A0 ES 533995A0 ES 533995 A ES533995 A ES 533995A ES 533995 A ES533995 A ES 533995A ES 533995 A0 ES533995 A0 ES 533995A0
Authority
ES
Spain
Prior art keywords
imidasols
preparing
procedure
preparing imidasols
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES533995A
Other languages
English (en)
Other versions
ES8506017A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Publication of ES8506017A1 publication Critical patent/ES8506017A1/es
Publication of ES533995A0 publication Critical patent/ES533995A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28Oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/28Oxygen atom
    • C07D473/30Oxygen atom attached in position 6, e.g. hypoxanthine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/40Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
ES533995A 1983-07-05 1984-07-04 Procedimiento para preparar imidasoles Granted ES533995A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833324115 DE3324115A1 (de) 1983-07-05 1983-07-05 Neue imidazole, ihre herstellung und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
ES8506017A1 ES8506017A1 (es) 1985-06-16
ES533995A0 true ES533995A0 (es) 1985-06-16

Family

ID=6203136

Family Applications (4)

Application Number Title Priority Date Filing Date
ES533995A Granted ES533995A0 (es) 1983-07-05 1984-07-04 Procedimiento para preparar imidasoles
ES541660A Expired ES8603478A1 (es) 1983-07-05 1985-03-28 Procedimiento para preparar nuevos imidazoles
ES541662A Granted ES541662A0 (es) 1983-07-05 1985-03-28 Procedimiento para preparar nuevos imidazoles
ES541661A Expired ES8603479A1 (es) 1983-07-05 1985-03-28 Procedimiento para preparar nuevos imidazoles

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES541660A Expired ES8603478A1 (es) 1983-07-05 1985-03-28 Procedimiento para preparar nuevos imidazoles
ES541662A Granted ES541662A0 (es) 1983-07-05 1985-03-28 Procedimiento para preparar nuevos imidazoles
ES541661A Expired ES8603479A1 (es) 1983-07-05 1985-03-28 Procedimiento para preparar nuevos imidazoles

Country Status (18)

Country Link
US (2) US4670438A (es)
EP (1) EP0130461A3 (es)
JP (1) JPS6036486A (es)
KR (1) KR850001208A (es)
AU (1) AU3032384A (es)
DD (1) DD224851A5 (es)
DE (1) DE3324115A1 (es)
DK (1) DK326484A (es)
ES (4) ES533995A0 (es)
FI (1) FI842666A (es)
GR (1) GR82380B (es)
HU (1) HU194878B (es)
IL (1) IL72298A0 (es)
NO (1) NO842684L (es)
NZ (1) NZ208779A (es)
PH (1) PH21496A (es)
PT (1) PT78836B (es)
ZA (1) ZA845103B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346640A1 (de) * 1983-12-23 1985-07-04 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazolderivate, deren herstellung und diese verbindungen enthaltende arzneimittel
DE3445299A1 (de) * 1984-12-12 1986-06-19 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE3522230A1 (de) * 1985-06-21 1987-01-02 Thomae Gmbh Dr K Neue 2-arylimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US4783530A (en) * 1986-11-13 1988-11-08 Marion Laboratories, Inc. 8-arylxanthines
GB8804016D0 (en) * 1988-02-22 1988-03-23 Boots Co Plc Therapeutic agents
DE3929864A1 (de) * 1989-09-08 1991-03-14 Nordmark Arzneimittel Gmbh Verfahren zur herstellung von theophyllin-pellets
EP0434038A1 (en) * 1989-12-22 1991-06-26 Takeda Chemical Industries, Ltd. Fused imidazole derivatives, their production and use
US5877176A (en) * 1991-12-26 1999-03-02 Cornell Research Foundation, Inc. Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
JP2534423B2 (ja) * 1991-12-26 1996-09-18 コーネル・リサーチ・ファンデーション・インコーポレイテッド 酸化窒素の過剰生産から生じる血管失調を阻止する阻害剤
EP0577025A3 (de) * 1992-07-01 1998-02-04 Hoechst Aktiengesellschaft Angiotensin-II-Rezeptorantagonisten zur Behandlung und Prophylaxe von koronaren Herzerkrankungen
CN1118600A (zh) * 1993-02-26 1996-03-13 先灵公司 2-苄基-多环鸟嘌呤衍生物以及制备它们的方法
CA2131134A1 (en) * 1993-09-17 1995-03-18 Gerhard Stucky Process for preparing imidazopyridine derivatives
CA2131680C (en) * 1993-09-17 2006-11-07 Gerhard Stucky Process for preparing imidazopyridine derivatives
US5502050A (en) * 1993-11-29 1996-03-26 Cornell Research Foundation, Inc. Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis
US6887690B2 (en) 2001-06-22 2005-05-03 Pe Corporation Dye-labeled ribonucleotide triphosphates
JP4127204B2 (ja) * 2003-12-17 2008-07-30 セイコーエプソン株式会社 液晶表示装置の製造方法
US8168658B2 (en) * 2006-02-28 2012-05-01 Merck Sharp & Dohme Corp. Inhibitors of histone deacetylase
JP2010531358A (ja) * 2007-06-27 2010-09-24 メルク・シャープ・エンド・ドーム・コーポレイション ヒストン脱アセチル化酵素阻害剤としてのピリジル及びピリミジニル誘導体
WO2009002495A1 (en) 2007-06-27 2008-12-31 Merck & Co., Inc. 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
US20090197880A1 (en) * 2007-07-13 2009-08-06 Genelabs Technologies, Inc. Anti-viral compounds, compositions, and methods of use

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3660397A (en) * 1970-04-17 1972-05-02 Merck & Co Inc Imidazo(4 5-b)pyrazines
US3922345A (en) * 1971-10-29 1975-11-25 Pfizer Pyrimidinones and hydroxy pyrimidines
US3985891A (en) * 1973-02-03 1976-10-12 Boehringer Ingelheim Gmbh 2-Phenyl-imidazo (4,5-b)pyridines and salts thereof
DE2305339C3 (de) * 1973-02-03 1980-05-08 Dr. Karl Thomae Gmbh, 7950 Biberach Imidazo [4,5-b] pyridine, ihre Herstellung und ihre Verwendung als Cardiötonica
EP0011399A1 (en) * 1978-11-11 1980-05-28 FISONS plc N-substituted theophyllines, processes for their preparation and pharmaceutical compositions containing them
DE2927988A1 (de) * 1979-07-11 1981-02-05 Thomae Gmbh Dr K Neue 8-phenyl-purine, deren herstellung und deren verwendung als arzneimittel
DE2927987A1 (de) * 1979-07-11 1981-02-05 Thomae Gmbh Dr K Neue 2-alkoxyphenyl-imidazo eckige klammer auf 4,5-b eckige klammer zu pyridine, deren herstellung und deren verwendung als arzneimittel
DE3037464A1 (de) * 1980-10-03 1982-05-19 Dr. Karl Thomae Gmbh, 7950 Biberach 6-hydroxy-2-phenyl-imidazo 4,5-b zu pyridine, ihre herstellung und diese sie enthaltende arzneimittel
DE3044497A1 (de) * 1980-11-26 1982-06-24 Dr. Karl Thomae Gmbh, 7950 Biberach Neues verfahren zur herstellung von imidazo(4,5-b)pyridinen und -pyrimidinen
GB2091249A (en) * 1980-12-23 1982-07-28 Fordonal Sa Xanthine derivatives
DE3273461D1 (en) * 1981-08-19 1986-10-30 Merck Patent Gmbh 2-arylimidazopyridines
ES517193A0 (es) * 1981-11-10 1983-12-01 Wellcome Found Un procedimiento para la preparacion de nuevos derivados de imidazo (4,5-c)piridina.
US4452788A (en) * 1982-04-21 1984-06-05 Warner-Lambert Company Substituted 8-phenylxanthines
IL68495A0 (en) * 1982-05-03 1983-07-31 Lilly Co Eli 2-phenylimidazo(4,5-c)pyridines
DE3217583A1 (de) * 1982-05-11 1983-11-17 Merck Patent Gmbh, 6100 Darmstadt 2-aryl-tetraazaindene
DE3224512A1 (de) * 1982-07-01 1984-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazolderivate, ihre herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
ES541661A0 (es) 1985-12-16
FI842666A0 (fi) 1984-07-03
PH21496A (en) 1987-11-10
US4670438A (en) 1987-06-02
ES8506017A1 (es) 1985-06-16
EP0130461A2 (de) 1985-01-09
ZA845103B (en) 1986-03-26
PT78836A (de) 1984-08-01
ES8603480A1 (es) 1985-12-16
ES541660A0 (es) 1985-12-16
GR82380B (es) 1984-12-13
AU3032384A (en) 1985-01-10
US4766130A (en) 1988-08-23
ES8603479A1 (es) 1985-12-16
HU194878B (en) 1988-03-28
DK326484A (da) 1985-01-06
PT78836B (de) 1986-10-21
JPS6036486A (ja) 1985-02-25
ES541662A0 (es) 1985-12-16
KR850001208A (ko) 1985-03-16
DD224851A5 (de) 1985-07-17
DK326484D0 (da) 1984-07-03
EP0130461A3 (de) 1987-05-06
HUT34475A (en) 1985-03-28
FI842666A (fi) 1985-01-06
IL72298A0 (en) 1984-11-30
DE3324115A1 (de) 1985-01-17
ES8603478A1 (es) 1985-12-16
NZ208779A (en) 1988-02-29
NO842684L (no) 1985-01-07

Similar Documents

Publication Publication Date Title
ES534787A0 (es) Procedimiento para preparar etinglicoles
ES535978A0 (es) Procedimiento para preparar derivados de tiazol
ES544204A0 (es) Procedimiento para preparar dialcoxipiridinas
ES542976A0 (es) Procedimiento para preparar pirrolo-bencimidazoles
ES537992A0 (es) Procedimiento para preparar 2-fenil-imidazoles
ES536138A0 (es) Procedimiento para preparar derivados azolicos
ES533995A0 (es) Procedimiento para preparar imidasoles
ES539255A0 (es) Procedimiento para preparar derivados de isoquinoleina
ES535534A0 (es) Procedimiento para la obtencion de -aril-1h-azol-1-etanoles
MX158200A (es) Procedimiento para preparar dimetileter
ES523938A0 (es) Procedimiento para preparar n-fosfonometilglicina
MX157033A (es) Procedimiento para preparar derivados de pirrolo quinoleina
ES534227A0 (es) Procedimiento para preparar piridinas
ES543691A0 (es) Procedimiento para preparar nuevos n-sustituido-2-(1-imida- zolil)-indoles
AR226634A1 (es) Procedimiento para preparar cligolaldehido
ES534377A0 (es) Procedimiento para preparar derivados de antraciclina
MX7403E (es) Procedimiento para preparar derivados de benzoil-ureas
ES530037A0 (es) Procedimiento para preparar imidazolamidas
ES533024A0 (es) Procedimiento para preparar meta-o para-isopropenil-alfa-alfa-dimetilbencilamina
ES525235A0 (es) Procedimiento para preparar n-fosfonometilglicina
ES525085A0 (es) Procedimiento para preparar n-alil-olalquil-tionocarbamatos
ES530626A0 (es) Procedimiento para preparar derivados de ciano-2-imidazopiridina
ES544074A0 (es) Procedimiento para preparar naftoxacinas
ES528807A0 (es) Procedimiento para preparar compuestos de ftalocianina
ES532142A0 (es) Procedimiento para preparar derivados acilaminofenolicos